全文获取类型
收费全文 | 102761篇 |
免费 | 11811篇 |
国内免费 | 4844篇 |
专业分类
耳鼻咽喉 | 1141篇 |
儿科学 | 2004篇 |
妇产科学 | 1096篇 |
基础医学 | 6932篇 |
口腔科学 | 2205篇 |
临床医学 | 13737篇 |
内科学 | 11835篇 |
皮肤病学 | 1351篇 |
神经病学 | 3662篇 |
特种医学 | 4329篇 |
外国民族医学 | 3篇 |
外科学 | 9812篇 |
综合类 | 21976篇 |
现状与发展 | 13篇 |
一般理论 | 9篇 |
预防医学 | 13512篇 |
眼科学 | 1589篇 |
药学 | 10408篇 |
119篇 | |
中国医学 | 8450篇 |
肿瘤学 | 5233篇 |
出版年
2024年 | 494篇 |
2023年 | 1506篇 |
2022年 | 2859篇 |
2021年 | 3815篇 |
2020年 | 3430篇 |
2019年 | 1992篇 |
2018年 | 2475篇 |
2017年 | 2942篇 |
2016年 | 2511篇 |
2015年 | 4077篇 |
2014年 | 5067篇 |
2013年 | 6618篇 |
2012年 | 8224篇 |
2011年 | 8616篇 |
2010年 | 7714篇 |
2009年 | 7010篇 |
2008年 | 6981篇 |
2007年 | 6796篇 |
2006年 | 6111篇 |
2005年 | 4876篇 |
2004年 | 3625篇 |
2003年 | 3016篇 |
2002年 | 2512篇 |
2001年 | 2345篇 |
2000年 | 1790篇 |
1999年 | 1113篇 |
1998年 | 610篇 |
1997年 | 601篇 |
1996年 | 591篇 |
1995年 | 513篇 |
1994年 | 420篇 |
1993年 | 395篇 |
1992年 | 565篇 |
1991年 | 539篇 |
1990年 | 499篇 |
1989年 | 539篇 |
1988年 | 468篇 |
1987年 | 434篇 |
1986年 | 438篇 |
1985年 | 412篇 |
1984年 | 338篇 |
1983年 | 303篇 |
1982年 | 213篇 |
1981年 | 185篇 |
1979年 | 217篇 |
1978年 | 192篇 |
1977年 | 177篇 |
1976年 | 160篇 |
1974年 | 165篇 |
1973年 | 147篇 |
排序方式: 共有10000条查询结果,搜索用时 2 毫秒
91.
B.E. Jones C.B. Boylan M. Fritsche M. Juhasz C. Jackson S.J. Wiegand C. Hyman R.M. Lindsay C.A. Altar 《Brain research》1996,709(2):275
Rat models of Parkinson's disease typically employ a rapid nigral injection of 6-hydroxydopamine (6-OHDA) to produce a near-complete loss of nigrostriatal dopamine neurons, and thus model end stage disease. The present report describes the use of a continuous, low dose infusion of 6-OHDA into the striatum which produces a terminal axotomy of nigrostriatal dopamine neurons and protracted behavioral response. A solution of 6-OHDA in 0.4% ascorbate, delivered at 37°C from osmotic minipumps, was stable for 8 days as determined by its retained toxicity to a dopaminergic neuroblastoma cell line. The continuous infusion of 0.2 μg 6-OHDA per h did not affect the striatal uptake of [3H]GABA, [3H]choline, or [3H]glutamate but reduced [3H]dopamine uptake by 55% within 1.5 days after the start of the infusion. The striatal infusion of 6-OHDA produced a dose-dependent reduction of striatal dopamine and DOPAC levels but did not alter HVA, 5-HT, or 5-HIAA. An increase in amphetamine-induced ipsiversive rotations occurred within 1.5 days after the acute striatal injection of 20 μg or 30 μg of 6-OHDA but required 4 days to develop with the continuous 6-OHDA infusion. The topography of the lesion mapped by [3H]mazindol binding showed that, begining by 1.5 days, a diffuse depletion of terminals encompassed much of the striatum in the 30 μg acute injection group, whereas in the continuously infused rats, the lesion was apparent only by 4 days and was restricted to a smaller and more completely lesioned area. Unlike acutely lesioned animals, continuously infused rats revealed no obvious loss of dopamine neurons in the pars compacta by 5 weeks after 6-OHDA. The continuous striatal infusion of 6-OHDA can produce a topographically limited terminal axotomy of dopamine neurons and a protracted behavioral impairment. 相似文献
92.
93.
上颌阻生尖牙的临床诊断与治疗 总被引:2,自引:0,他引:2
目的:对阻生上颌尖牙的病因、临床检查、诊断及其相应的治疗进行了临床研究。方法:选取57例上颌尖牙阻生患者,通过病史询问、临床检查、X线片和模型测量的综合分析,从临床角度对阻生牙进行了诊断分类,采用不同的方法进行了矫治,并对矫治效果进行了评估。结果:采取适宜有效的治疗办法,均取得了满意的治疗效果,牙周膜愈合成功率达100%,活髓牙成功率达93.6%,牙龈形态良好者达89.4%。结论:尖牙阻生情况各异,治疗方法多样,根据临床分类选择合适的治疗方法,是矫治成功的关键。 相似文献
94.
Lois Jackson Wayne Putnam Peter Twohig Frederick Burge Kelly Nicol Jafna Cox 《Health, risk & society》2004,6(3):239-255
The management of patients through the use of evidence-based medicine has become the 'mantra' of medicine within many Western countries. Evidence-based medicine is aimed at providing the best objective, scientific care to all patients, and reducing as far as possible patients' risks of disease and complications from disease. Based on family physicians' discussions of the use of evidence-based recommendations for two cardiac diseases, this paper explores how subjectively-based trust enters into family physicians' decision to use evidence-based medicine. In addition, we show how trust influences physicians' work of recommending evidence-based medicine to patients, and physicians' perceptions of why patients follow recommendations aimed at risk reduction. We conclude that although much of the current discussion about evidence-based medicine assumes a 'rational' model of physician behaviour based on the application of the 'best objective scientific' results, subjectively-based perceptions of trust influence physician practices, and point to the need to understand the power of relational issues in influencing physician practices even when utilizing evidence-based knowledge. 相似文献
95.
经胼胝体穹隆间人路切除下丘脑内型错构瘤 总被引:10,自引:0,他引:10
目的探讨下丘脑内型错构瘤的手术治疗方法。方法报告4例下丘脑内型错构瘤,采用右额后开颅经胼胝体-透明隔-穹隆间入路切除下丘脑内型错构瘤。结果4例均为儿童,男女为31,均以癫痫发作为主要症状,错构瘤为大部切除或部分切除,术后低钠血症1例,轻度尿崩1例,无其他合并症。随诊半年至1.5年,无任何癫痫发作。结论经胼胝体-透明膈-穹隆间入路是下丘脑内型错构瘤的最佳手术入路,错构瘤大部切除或部分切除即可取得满意疗效。 相似文献
96.
脑囊虫病人血清、脑脊液中抗体在MRI各期的变化 总被引:1,自引:0,他引:1
目的 检测脑囊虫病人血清和脑脊液中抗体在MRI各期的变化。方法 用抑制性ELISA法检测血清及脑脊液中的抗体。同时根据MRI表现将病例分为活动期、退变期、非活动期。结果 在69个病例中,脑脊液中抗体阳性率分别是:活动期75.00%,退变期62.50%,非活动期17.24%;血清中是81.25%、16.67%、22.22%。在相应各期中,脑脊液和血清抗体阳性率无显著性差别。结论 在影像学的不同时期抗体阳性率存在明显的变化。 相似文献
97.
98.
肺癌组织中血管内皮生长因子受体Flt1及KDR的表达及其与肿瘤转移和预后的关系 总被引:1,自引:1,他引:0
①目的 探讨肺癌中血管内皮生长因子受体Flt1、KDR的表达与其转移及预后的关系。②方法 应用免疫组织化学PowerVisionTM PV90 0 0法 ,测定 75例肺癌标本中Flt1、KDR的表达。③结果 肺癌组织中Flt1、KDR的表达较为广泛 ,主要位于肿瘤细胞胞浆及胞膜上 ,纤维母细胞和血管内皮细胞胞浆中亦有表达。Flt1、KDR在肿瘤细胞中的阳性率均显著高于在间质纤维母细胞中的表达 (χ2 =6 .0 7、5 .88,P <0 .0 5 )。肿瘤细胞及纤维母细胞中该两种受体的阳性率在不同年龄、不同性别及不同病理类型、不同病理分级之间差异均无显著性 (χ2 =0 .0 1~4 .84 ,P >0 .0 5 ;P =0 .2 9~ 0 .79)。肿瘤细胞中Flt1、KDR的阳性表达率在 3组不同大小的肿瘤间差异均有显著性(χ2 =1 0 .35、7.2 9,P <0 .0 5 ) ,而纤维母细胞中差异均无显著性 (χ2 =2 .86、2 .5 6 ,P >0 .0 5 ) ;肿瘤细胞及纤维母细胞中Flt1、KDR的阳性率在淋巴结有、无转移两组间的差异均有显著性 (χ2 =4 .72~ 9.32 ,P <0 .0 5 ) ,在 3组不同术后生存时间病人间亦均有显著性差异 (χ2 =8.81~ 1 9.1 9,P <0 .0 5 )。肿瘤细胞中Flt1、KDR的表达呈极显著性正相关 (r =0 .4 4 ,P <0 .0 1 )。④结论 肺癌的生长主要依赖自分泌机制 ,联合检测Flt1、KDR可能对肺癌转移 相似文献
99.
Mark Foord BA MA Julie Savory BA MA MCiH Dianne Sodhi BA MA MCiH 《Health & social care in the community》2004,12(2):126-133
This paper reflects on a research project funded by a consortium of leading sheltered housing (SH) providers and their regulatory body, the Housing Corporation. The project aimed to ascertain which aspects of SH older people perceived to be central to their satisfaction and the methods they judged most appropriate to measuring this. We outline key policy developments of importance to SH (specifically the development of performance measurement regimes), and changes in the nature of SH, which are driving providers to re‐evaluate how they measure user satisfaction. We discuss the aims of the project, our methodology and findings, and conclude by raising critical questions about the process of measuring satisfaction within an increasingly managerialised housing system. We argue that this favours standardised methods of information gathering (such as questionnaires) rather than engage with clients in order to develop methods and systems capable of eliciting qualitative issues of concern to them. Our conclusions are, we believe, applicable to health and social care provision, where similar tensions exist around performance measurement and user satisfaction. 相似文献
100.